Evidence map›Paper›PMID 37418417›Full record

ArticleNeurosurgery2023

International Tuberculum Sellae Meningioma Study: Preoperative Grading Scale to Predict Outcomes and Propensity-Matched Outcomes by Endonasal Versus Transcranial Approach.

Stephen T Magill, Theodore H Schwartz, William T Couldwell, Paul A Gardner, Carl B Heilman, Chandranath Sen, Ryojo Akagami, Paolo Cappabianca, Daniel M Prevedello, Michael W McDermott and 1 more

Abstract read
In one paragraph

Article in Neurosurgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Endonasal Route for Tuberculum and Planum Meningiomas.Advances and technical standards in neurosurgery · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stephen T MagillDepartment of Neurological Surgery, Northwestern University, Chicago , Illinois , USA.ORCID 0000-0002-5257-7835
Theodore H SchwartzDepartment of Neurological Surgery, Cornell University, New York , New York , USA.ORCID 0000-0003-4464-7394
William T CouldwellDepartment of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City , Utah , USA.ORCID 0000-0002-0070-0053
Paul A GardnerDepartment of Neurological Surgery, University of Pittsburgh, Pittsburgh , Pennsylvania , USA.
Carl B HeilmanDepartment of Neurological Surgery, Tufts University, Boston , Massachusetts , USA.ORCID 0000-0001-9744-1010
Chandranath SenDepartment of Neurological Surgery, New York University, New York , New York , USA.ORCID 0000-0003-1603-2958
Ryojo AkagamiDepartment of Neurological Surgery, University of British Columbia, Vancouver , British Columbia , Canada.ORCID 0000-0001-9973-3922
Paolo CappabiancaDepartment of Neurological Surgery, Universita degli Studi di Napoli Federico II, Naples , Italy.ORCID 0000-0001-8277-498
Daniel M PrevedelloDepartment of Neurological Surgery, The Ohio State University, Columbus , Ohio , USA.ORCID 0000-0003-0214-2339
Michael W McDermottMiami Neuroscience Institute, Baptist Health South Florida, Miami , Florida , USA.
International Tuberculum Sellae Meningioma Study

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
NCATS NIH HHS UL1 TR002345
6 · The paper itself

Abstract

BACKGROUND AND

objectivesTuberculum sellae meningiomas are resected via an expanded endonasal (EEA) or transcranial approach (TCA). Which approach provides superior outcomes is debated. The Magill-McDermott (M-M) grading scale evaluating tumor size, optic canal invasion, and arterial involvement remains to be validated for outcome prediction. The objective of this study was to validate the M-M scale for predicting visual outcome, extent of resection (EOR), and recurrence, and to use propensity matching by M-M scale to determine whether visual outcome, EOR, or recurrence differ between EEA and TCA.

methodsForty-site retrospective study of 947 patients undergoing tuberculum sellae meningiomas resection. Standard statistical methods and propensity matching were used.

resultsThe M-M scale predicted visual worsening (odds ratio [OR]/point: 1.22, 95% CI: 1.02-1.46, P = .0271) and gross total resection (GTR) (OR/point: 0.71, 95% CI: 0.62-0.81, P < .0001), but not recurrence ( P = .4695). The scale was simplified and validated in an independent cohort for predicting visual worsening (OR/point: 2.34, 95% CI: 1.33-4.14, P = .0032) and GTR (OR/point: 0.73, 95% CI: 0.57-0.93, P = .0127), but not recurrence ( P = .2572). In propensity-matched samples, there was no difference in visual worsening ( P = .8757) or recurrence ( P = .5678) between TCA and EEA, but GTR was more likely with TCA (OR: 1.49, 95% CI: 1.02-2.18, P = .0409). Matched patients with preoperative visual deficits who had an EEA were more likely to have visual improvement than those undergoing TCA (72.9% vs 58.4%, P = .0010) with equal rates of visual worsening (EEA 8.0% vs TCA 8.6%, P = .8018).

conclusionThe refined M-M scale predicts visual worsening and EOR preoperatively. Preoperative visual deficits are more likely to improve after EEA; however, individual tumor features must be considered during nuanced approach selection by experienced neurosurgeons.

Indexed as

Meningeal NeoplasmsMeningiomaNeuroendoscopySkull Base NeoplasmsHumansRetrospective StudiesSella TurcicaTreatment Outcome

Identifiers

PMID37418417
PMCPMC12245370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.